Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
7 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Efficacy and safety of tisotumab vedotin in previously treated recurrent or metastatic cervical cancer (innovaTV 204/GOG-3023/ENGOT-cx6): a multicentre, open-label, single-arm, phase 2 study.
Lancet Oncol. 2021 May;22(5):609-619. doi: 10.1016/S1470-2045(21)00056-5. Epub 2021 Apr 9.
Lancet Oncol. 2021.
PMID: 33845034
Clinical Trial.
Patient characteristics, treatment patterns, and clinical outcomes among patients with previously treated recurrent or metastatic cervical cancer: A community oncology-based analysis.
Alholm Z, Monk BJ, Ting J, Pulgar S, Boyd M, Sudharshan L, Bains S, Nicacio L, Coleman RL.
Alholm Z, et al.
Gynecol Oncol. 2021 May;161(2):422-428. doi: 10.1016/j.ygyno.2021.03.002. Epub 2021 Mar 17.
Gynecol Oncol. 2021.
PMID: 33741208
Item in Clipboard
Tisotumab vedotin in Japanese patients with recurrent/metastatic cervical cancer: Results from the innovaTV 206 study.
Yonemori K, Kuboki Y, Hasegawa K, Iwata T, Kato H, Takehara K, Hirashima Y, Kato H, Passey C, Buchbjerg JK, Harris JR, Andreassen CM, Nicacio L, Soumaoro I, Fujiwara K.
Yonemori K, et al.
Cancer Sci. 2022 Aug;113(8):2788-2797. doi: 10.1111/cas.15443. Epub 2022 Jun 15.
Cancer Sci. 2022.
PMID: 35633184
Free PMC article.
Clinical Trial.
Item in Clipboard
A dose-escalation phase I trial of nimotuzumab, an antibody against the epidermal growth factor receptor, in patients with advanced solid malignancies.
You B, Brade A, Magalhaes JM, Siu LL, Oza A, Lovell S, Wang L, Hedley DW, Nicacio LV, Chen EX.
You B, et al. Among authors: nicacio lv.
Invest New Drugs. 2011 Oct;29(5):996-1003. doi: 10.1007/s10637-010-9444-0. Epub 2010 May 8.
Invest New Drugs. 2011.
PMID: 20454832
Clinical Trial.
Item in Clipboard
Phase I clinical trial of the anti-EGFR monoclonal antibody nimotuzumab with concurrent external thoracic radiotherapy in Canadian patients diagnosed with stage IIb, III or IV non-small cell lung cancer unsuitable for radical therapy.
Bebb G, Smith C, Rorke S, Boland W, Nicacio L, Sukhoo R, Brade A.
Bebb G, et al.
Cancer Chemother Pharmacol. 2011 Apr;67(4):837-45. doi: 10.1007/s00280-010-1379-9. Epub 2010 Jun 20.
Cancer Chemother Pharmacol. 2011.
PMID: 20563810
Clinical Trial.
Item in Clipboard
Sequencing of Cabazitaxel and Abiraterone Acetate After Docetaxel in Metastatic Castration-Resistant Prostate Cancer: Treatment Patterns and Clinical Outcomes in Multicenter Community-Based US Oncology Practices.
Sonpavde G, Bhor M, Hennessy D, Bhowmik D, Shen L, Nicacio L, Rembert D, Yap M, Schnadig I.
Sonpavde G, et al.
Clin Genitourin Cancer. 2015 Aug;13(4):309-318. doi: 10.1016/j.clgc.2014.12.019. Epub 2015 Jan 9.
Clin Genitourin Cancer. 2015.
PMID: 25743206
Free article.
Item in Clipboard
Treatment patterns and clinical effectiveness in metastatic castrate resistant prostate cancer after first-line docetaxel.
Houts AC, Hennessy D, Walker MS, Nicacio L, Thompson SF, Miller PJ, Somer BG.
Houts AC, et al.
J Community Support Oncol. 2014 Sep;12(9):321-8. doi: 10.12788/jcso.0072.
J Community Support Oncol. 2014.
PMID: 25848909
Item in Clipboard
Cite
Cite